Alnylam Pharmaceuticals Aktie
277,20
EUR
+2,70
EUR
+0,98
%
317,61
USD
-10,78
USD
-3,28
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung